Specifications
- Assay duration:Multiple steps
- Assay Type (ELISA with LOV):Sandwich
- Format:Pre-coated
- Primary antibody reactivity:Human
- Target protein:Spectrin beta Chain, Brain 3/SPTBN4
- Description:Human spectrin beta chain, brain 3/SPTBN4 ELISA kit
- Size:96 tests
- Sample Type:Serum, plasma, tissue homogenates and other biological fluids
- Cross Reactivity:Human Spectrin beta Chain, Brain 3/SPTBN4 ELISA kit exhibits high specificity and excellent specificity for the detection of human Spectrin beta Chain, Brain 3/SPTBN4. No significant cross-reactivity or interference between Spectrin beta Chain, Brain 3/SPTBN4 and analogues was observed.
- Detection Method:Colorimetric
- Time to Results:4 h 30 min
- Assay Principle:Quantitative
- Shelf Life:Store for 6 months at 4 °C
- Detection Range:0.156 - 10 ng/ml
- Storage Temperature:4 °C
- Sample Volume:100 μl
- Sensitivity:0.094 ng/ml
- Regulatory Status:RUO
- Cat. No.:76738-352
Specifications
About this item
Human Spectrin beta Chain, Brain 3/SPTBN4 ELISA kit is a sandwich Enzyme-Linked Immunosorbent Assay (sELISA) designed for the in vitro quantitative determination of human Spectrin beta Chain, Brain 3/SPTBN4 in serum, plasma, tissue homogenates, and other biological fluids.
- Ready-To-Use ELISA Kit
- Detection Range: 0.156 - 10 ng/ml
- Sensitivity: 0.094 ng/ml
- Sample Type: Serum, plasma, tissue homogenates, and other biological fluids
- Assay Precision: Intra-Assay: CV <8%, Inter-Assay: CV <10%
Human Spectrin beta Chain, Brain 3/SPTBN4 ELISA kit (A75027) employs the sandwich enzyme immunoassay technique for the quantitative measurement of human Spectrin beta Chain, Brain 3/SPTBN4 in serum, plasma, tissue homogenates, and other biological fluids. An antibody specific for Spectrin beta Chain, Brain 3/SPTBN4 has been pre-coated onto a 96-well microtiter plate. The standards and test samples are added into the wells and the Spectrin beta Chain, Brain 3/SPTBN4 present in each sample is bound to the wells by the immobilized antibody. Following incubation, the wells are washed and then incubated with Biotinylated Anti-Spectrin beta Chain, Brain 3/SPTBN4 Antibody, which binds the captured Spectrin beta Chain, Brain 3/SPTBN4 present in each well. Following incubation, unbound biotinylated detection antibody is removed by washing, and an HRP-Streptavidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is proportional to the amount of Spectrin beta Chain, Brain 3/SPTBN4 captured in each well. The concentration of Spectrin beta Chain, Brain 3/SPTBN4 can then be calculated by reading the O.D. absorbance at 450 nm in a microplate reader and referring to the standard curve.